No title
BACKGROUND: Blood-based biomarkers are a promising tool for early detection of Alzheimer's disease (AD). We recently showed that individuals with autosomal-dominant AD due to the E280A mutation in the presenilin1 gene (PSEN1) showed elevated levels of plasma tau phosphorylated at threonine 217 (P-tau217) and neurofilament light chain (NfL), as early as approximately 20 years before clinical onset.
